From the Department of Medicine, Saint Thomas Hospital, Nashville, TN (AEC, RWL); Departments of Internal Medicine, Divisions of General Internal Medicine and Center for Health Services Research and the VA Tennessee Valley Geriatric Research, Education and Clinical Center (GRECC) (EWE, SMG, BTP); Division of Allergy/Pulmonary/Critical Care Medicine (EWE, TDG, JCJ, JWWT, RWL), Department of Anesthesiology (PP), and Department of Biostatistics (AKS), Vanderbilt University School of Medicine, Nashville, TN; and the Multidisciplinary Neuroprotection Laboratory and the Departments of Medicine (Neurology) (DTL) and Critical Care, Duke University Medical Center, Durham, NC.
Supported, in part, by a grant from the Saint Thomas Foundation, Nashville, TN; the Paul Beeson Faculty Scholar Award from the Alliance for Aging Research (EWE); a K23 from the National Institutes of Health (AG01023-01A1) (EWE); grant 240803 from the Institute for the Study of Aging (DTL); and grant M01 RR00095 from the National Center for Research Resources, National Institute of Health.
Dr. Ely has received honoraria and grants from Pfizer, Lilly, and Hospira. The remaining authors have not disclosed any potential conflicts of interest.
Address requests for reprints to: E. Wesley Ely, MD, MPH, FACP, FCCM, ICU Cognitive Impairment Study Group, Center for Health Services Research, 6th Floor Medical Center East, #6109, Vanderbilt University Medical Center, Nashville, TN 37232-8300. E-mail: [email protected].
